期刊
CANCER RESEARCH
卷 76, 期 14, 页码 4136-4148出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-15-3121
关键词
-
类别
资金
- MRC [MR/L017172/1] Funding Source: UKRI
- Cancer Research UK [C491/A15951] Funding Source: Medline
- Medical Research Council [MR/L017172/1] Funding Source: Medline
- Cancer Research UK [18161, 18158, 15951, 22795] Funding Source: researchfish
- Cancer Research UK
- Versus Arthritis [18892] Funding Source: researchfish
- Medical Research Council [1483698, MR/L017172/1] Funding Source: researchfish
- Versus Arthritis
- Cancer Research UK [20613] Funding Source: researchfish
Antibodies that block T-cell-regulatory checkpoints have recently emerged as a transformative approach to cancer treatment. However, the clinical efficacy of checkpoint blockade depends upon inherent tumor immunogenicity, with variation in infiltrating T cells contributing to differences in objective response rates. Here, we sought to understand the molecular correlates of tumor-infiltrating T lymphocytes (TIL) in squamous cell carcinoma (SCC), using a systems biologic approach to integrate publicly available omics datasets with histopathologic features. We provide evidence that links TIL abundance and therapeutic outcome to the regulation of tumor glycolysis by EGFR and HIF, both of which are attractive molecular targets for use in combination with immunotherapeutics. (C)2016 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据